Bay Area Covid vaccine developer picks candidate, another manufacturing partner

A Peninsula company has zeroed in on a Covid-19 vaccine candidate to move into clinical trials as soon as this summer. Vaxart Inc. (NASDAQ: VXRT) of South San Francisco also said Wednesday that it picked Burlingame-based Kindred Biosciences Inc. (NASDAQ: KIN) as another manufacturing partner. Financial terms of the deal were not disclosed. Vaxart, working on a tablet form of a vaccine, is one of more than 100 organizations globally working on a cure for the novel coronavirus that causes Covid-19.…

Click to view original post